Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (14,5 Mio. €): SICHERHEITSTESTS IM LEBENSZYKLUS NANOTECHNOLOGIEFÄHIGER MEDIZINISCHER TECHNOLOGIEN FÜR DIE GESUNDHEIT. Hor28.03.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Text

SICHERHEITSTESTS IM LEBENSZYKLUS NANOTECHNOLOGIEFÄHIGER MEDIZINISCHER TECHNOLOGIEN FÜR DIE GESUNDHEIT.

Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB) To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).


Geförderte Unternehmen:

Firmenname Förderungssumme
Biocat La Fundacio Bioregio de Catalunya 0,00 €
Bioindustry Park Silvano Fumero S.p.A. Societa'Benefit 0,00 €
Biokeralty Research Institute AIE 1.572.119 €
Biowin ASBL 0,00 €
Business Turku OY AB 0,00 €
Centre National de la Recherche Scientifique CNRS 455.605 €
China Pharmaceutical University 0,00 €
Consorcio Centro de Investigacion Biomedica en Red M.P 1.040.970 €
Council OF European Bioregions 492.500 €
Departamento de Salud Gobierno Vasco 267.322 €
Elliniki Enosi Biotechnologias Astiki Mi Kerdoskopiki Etairia 0,00 €
Euroscan International Network e. V. 346.250 €
Fundacao Gimm - Gulbenkian Institute For Molecular Medicine 806.065 €
Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca 649.580 €
Fundacion Tecnalia Research & Innovation 597.526 €
Fundacion Vasca de Innovacion e Investigacion Sanitarias 0,00 €
Greendecision Srl 558.075 €
Helia Biomonitoring B.V. 365.663 €
Hubei Gedian Humanwell Pharmaceutical CO. Ltd. 0,00 €
Institutul de Chimie Fizica - Ilie Murgulescu 379.250 €
International Iberian Nanotechnology Laboratory 690.063 €
Keralty SAS 297.500 €
Maraca International 158.568 €
National Center FOR Nanoscience AND Technology 0,00 €
Resonant Circuits Ltd. 578.786 €
Sintef AS 822.788 €
Statens Arbeidsmiljoinstitutt 656.250 €
Stryker Trauma GmbH 528.522 €
Technische Universiteit Eindhoven 428.750 €
Tecnalia Serbia d.o.o. Beograd 0,00 €
Tecnologia Navarra de Nanoproductos SL 247.625 €
The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin 604.951 €
The University of Liverpool 717.145 €
Universita Degli Studi Di Pavia 578.689 €
Universite d'AIX Marseille 0,00 €
Vlaamse Instelling Voor Technologisch Onderzoek N.V. 536.250 €

Quelle: https://cordis.europa.eu/project/id/814607

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.